Cognitive Neuroscience of Autism Spectrum Disorders
NCT01031407
Adult, Asperger Syndrome
Bethesda, Maryland, United States
View Trial DetailsNCT Number: NCT01669889
This multi-center, non-drug study will explore the relationship between exploratory biomarkers and functional dimensions in male adult individuals with Autistic Disorder or Asperger's Syndrome and healthy volunteer controls. Subjects will undergo a number of assessments on study visit Day 1.
Looking for future studies?
Notify Me18 year–45 year
Male
Observational
Los Ageles, California, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Individuals with Autistic Disorder or Asperger's Syndrome:
Healthy controls:
Exclusion criteria
General exclusion criteria:
Additionally for individuals with Autistic Disorder or Asperger's Syndrome:
Additionally for healthy controls:
Time frame: approximately 5 months
Time frame: approximately 5 months
Hoffmann-La Roche
Industry
A Multi-center, Non-drug Study to Explore the Relationship Between Exploratory Biomarkers and Functional Dimensions in Individuals With Autistic Disorder or Asperger's Syndrome.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01031407
Adult, Asperger Syndrome
Bethesda, Maryland, United States
View Trial DetailsNCT04654260
Aberrant Motor Behavior in Dementia, Aggression
New Haven, Connecticut, United States
View Trial DetailsNCT04788537
Asperger Syndrome, Autism
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT03170453
Asperger Syndrome, Autism Spectrum Disorder
Pittsburgh, Pennsylvania, United States
View Trial Details